Evidence map›Paper›PMID 39953579›Full record

ArticleOrphanet journal of rare diseases2025

Rates of mental health concerns among individuals assessed at the GoodHope Ehlers-Danlos Syndrome Clinic.

P Maxwell Slepian, Kristina Axenova, Molly McCarthy, Rachel Siegal, Keisha Gobin, Aliza Weinrib, Stephanie Buryk-Iggers, Daniel Santa Mina, Laura McGillis, Nimish Mittal and 2 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

P Maxwell SlepianGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada. maxwell.slepian@uhn.ca.ORCID http://orcid.org/0000-0003-0435-4191
Kristina AxenovaGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Molly McCarthyGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Rachel SiegalGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Keisha GobinDepartment of Psychology, York University, Toronto, Ontario, Canada.
Aliza WeinribGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Stephanie Buryk-IggersGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Daniel Santa MinaGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Laura McGillisGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Nimish MittalGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Joel KatzGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.
Hance ClarkeGoodHope Ehlers-Danlos Syndrome Clinic, Toronto General Hospital, 11 PMB 100D, 200 Elizabeth St, Toronto, ON, CA, M5G 2C4, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Past research has indicated that individuals with Ehlers-Danlos Syndromes (EDS) and Generalized Hypermobililty Spectrum Disorder (G-HSD) report psychological and psychiatric symptoms, particularly anxiety disorders and depressive symptoms, at much greater rates than the general population. However, these studies have been primarily conducted in small samples at European centres. We report a retrospective chart review from 1035 consecutive patients (88% female) assessed for EDS/G-HSD at the GoodHope EDS Clinic at Toronto General Hospital between June 2019 and June 2021. Prior to assessment, all patients completed self-reported mental health screening questions, the Inventory of Depressive and Anxiety Symptoms - Dysphoria scale, and the Borderline Symptom List-23. The majority of patients reported current or past anxiety or depressive symptoms (53-87%), and a substantial minority reported significant mental health concerns, including Posttraumatic Stress Disorder (4.7-34.8%), disordered eating (19%), self-harm (3-29.2%), and suicidal behaviour (7.8-18.6%). Patients did not differ by diagnostic category on self-report measures of dysphoria or borderline symptoms. Individuals with G-HSD reported higher rates of anxiety and depression in clinical interview than those diagnosed with non-hypermobile EDS, and endorsed a higher rate of having "struggled with anxiety or depression" on the mental health screening questionnaire than individuals not diagnosed with EDS/G-HSD. No other differences emerged across diagnostic groups. These findings highlight the need for psychological support for individuals with EDS or G-HSD.

Indexed as

Ehlers-Danlos SyndromeMental HealthAdolescentAdultAnxietyDepressionFemaleHumansMaleMiddle AgedRetrospective StudiesSelf-Injurious BehaviorYoung AdultAnxietyEhlers-danlos syndromeHypermobility spectrum disorderJoint hypermobilityPsychology

Identifiers

PMID39953579
PMCPMC11829448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.